Related Experiment Video
Updated: Sep 13, 2025

In Vitro Thrombosis Test for Ventricular Assist Devices
Published on: March 21, 2025
Temporal trends and risk factors for bleeding and thrombosis in pediatric ECMO: A multicenter cohort study
Kevin J Doré1, Carlton M Kelly2, Timothy T Cornell1
1Department of Pediatrics, Division of Critical Care Medicine, Stanford University School of Medicine, Stanford, CA, USA.
Insights
Bleeding and thrombosis are common in pediatric extracorporeal membrane oxygenation (ECMO) and their risks change over time. Prior bleeding or thrombosis influences future risk, suggesting dynamic anticoagulation strategies are needed for pediatric ECMO patients.
Area of Science:
- Pediatric critical care medicine
- Cardiovascular research
- Hematology
Background:
- Bleeding and thrombosis are significant complications in pediatric extracorporeal membrane oxygenation (ECMO), impacting patient outcomes.
- The time-dependent nature and predictors of these events in pediatric ECMO are not fully understood.
- Accurate risk assessment is crucial for managing anticoagulation and improving survival rates.
Purpose of the Study:
- To evaluate clinical predictors of bleeding and thrombotic events in pediatric patients undergoing ECMO.
- To analyze the time-to-event risks associated with bleeding and thrombosis during ECMO.
- To identify factors influencing the evolving risk of these complications.
Main Methods:
- Retrospective cohort study using the Pediatric ECMO Outcomes Registry (PEDECOR) from 2011 to 2024.
- Included 1444 pediatric patients (≤18 years) on their first ECMO run.
- Utilized time-varying Cox proportional hazards models to assess risk factors for bleeding and thrombosis.
Main Results:
- Bleeding occurred in 65% of patients, with a median time to first event of 2 days; thrombosis occurred in 28%, with a median time of 3 days.
- Prior thrombosis reduced early bleeding risk (HR: 0.39), but this effect reversed over time (crossover at 12.4 days).
- Prior bleeding reduced early thrombosis risk (HR: 0.49), reversing over time (crossover at 4.3 days). Sepsis was linked to thrombosis; central cannulation, cardiac surgery, and non-pulmonary indications were linked to bleeding.
Conclusions:
- Bleeding and thrombosis are frequent and dynamic risks during pediatric ECMO.
- The interplay between prior bleeding/thrombosis and subsequent events changes over the ECMO course.
- Findings support the need for adaptive anticoagulation strategies based on evolving patient risk profiles in pediatric ECMO.
Abstract:
IntroductionBleeding and thrombosis are major causes of morbidity and mortality in pediatric extracorporeal membrane oxygenation (ECMO), yet their evolving, time-dependent risks remain poorly defined. This study evaluated clinical predictors of bleeding and thrombotic events using time-to-event analysis.MethodsA retrospective cohort study was conducted using the Pediatric ECMO Outcomes Registry (PEDECOR) from October 2011 to September 2024. Patients aged ≤18 years undergoing their first ECMO run were included. Two time-varying Cox proportional hazards models assessed associations between prior complications and time to first bleed or thrombosis, adjusting for clinical and ECMO-related variables.ResultsAmong 1444 patients, median age was 0.4 years (IQR: 0.0-4.4), and 53.6% were male. Bleeding occurred in 65% and thrombosis in 28%. Time to first bleeding events had a median of 2 days (IQR: 0-4) while time to first thrombosis had a median of 3 days (IQR: 2-6). Prior thrombosis was associated with lower early bleeding risk (HR: 0.39, 95% CI: 0.25-0.62, p < 0.001), which reversed over time (interaction HR: 1.44, 95% CI: 1.08-1.92, p = 0.013; crossover at 12.4 days). Similarly, prior bleeding was associated with reduced early thrombosis risk (HR: 0.49, 95% CI: 0.34-0.71, p < 0.001), but reversed over time (interaction HR: 1.63, 95% CI: 1.26-2.11, p < 0.001; crossover at 4.3 days). Central cannulation, cardiac surgery, and non-pulmonary indications were associated with bleeding; sepsis was associated with thrombosis. Anticoagulant type and sex were not significant.ConclusionsBleeding and thrombosis are common and time-dependent in pediatric ECMO. These findings support dynamic anticoagulation strategies tailored to evolving risk.
Related Concept Videos
Venous Thrombosis IV: Nursing Management
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Venous Thrombosis III: Interprofessional Care
Pulmonary Embolism III: Nursing Management
Pulmonary Embolism I: Introduction

